Top of the Street: Elisa, Burberry, Astrazeneca
A round-up of notable broker activity this morning from Europe's top-ranked* analysts:
** Barclays upgrades Finnish telecoms groupElisa ELISA.HE to "overweight" from "underweight" on expectations of solid service revenue growth from upselling in a Finnish market viewed as the strongest in Europe
** Berenberg raises Swiss semiconductor and vacuum solutions company Inficon Holding IFCN.S to "buy" from "hold", saying that recent share price correction provides a good entry point into "a high-quality company that is well positioned for a market recovery in 2025"
** Broker cuts British medical equipment maker Smith + Nephew SN.L to "hold" from "buy" citing less clear recovery pathafter a disappointing Q3, with headwinds in China leadingto guidance downgrades for 2024 and 2025
** RBC upgrades Burberry BRBY.L to "outperform" from "sector perform" with a Speculative Risk qualifier as it is potentially an acquisition target for Moncler MONC.MI or other industry players
** Deutsche Bank cuts Astrazeneca AZN.L to "sell" from "hold," as the company's "challenging"update for key next-gen lung cancer pipeline asset datopotamab raised further material questions over the asset and concerns on the potential 2025guidance outlook
(*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)
Reporting by Tiago Brandao and Olivier Cherfan
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
